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Introduction
In December 2019, a new coronavirus, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), broke out in the Chinese
province of Wuhan and rapidly infected hundreds of thousands of
people worldwide. Infected patients mostly exhibit general signs of
pneumonia (fever, dyspnea, coughing and desaturation) and a
presumably significant number of infected patients are
asymptomatic.
Purpose
Study of literature data on biomarkers of liver damage in patients
with COVID-19 infection that could provide information about liver
damage.
Material and methods
A study of the literature from the PubMed database was performed.
The keywords were used in the search process - "COVID-19", "liver
damage", "biomarkers".
Results
Lactate dehydrogenase, aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) are often elevated in COVID-19
patients, indicating liver damage. Recent reports point to the fact
that liver injury, by means of increased aminotransferase levels,
more frequently occurred in severe COVID-19 cases compared to
patients with mild symptoms.
Conclusions
Further studies are needed on the impact of SARS-CoV-2 virus on liver
cells.
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